Thursday, 21 October 2021

 

 

LATEST NEWS Make All Efforts For Instilling Confidence Of General Public In Law And Order Machinery- Cm To Punjab Police Youth To Be Deciding Factor In Vidhan Sabha Polls : Charanjit Singh Channi Massive protest against Cong MLA Joginderpal at Pathankot Police Commemoration Day observed at DPL Pulwama Intense Dengue control measures afoot Punjab Government To Come Up With A Roadmap To Revamp Education System : Pargat Singh The public knows who did corruption and who went to the court for the same : Vinod Thakur Central University of Punjab organized an Invited lecture on “Universal Human Values” Raja Warring's report card does not include any action against political transport mafia : Dinesh Chadha Tamannah Bhatia among top 10 most influential social media stars in south Being Punjabi an advantage in portraying a 'Sardar' : Pawan Malhotra Debina Bonnerjee's prosthetics for 'Shubho Bijoya' will leave you in shock Government recognizes Purzgars as vital pillar in Shawl Industry Police Martyrs Day observed at DPL Ganderbal, Pulwama Director Agriculture Kashmir inaugurates sale of Vegetable seedlings at Kitchen Garden, Lal Mandi Snow forecast : DC Bandipora reviews winter preparedness Disst. Adm. Kupwara organizes 4 block diwas programmes at Hayhama, Langate, Kalaroos, Tad Sonamarg to be promoted as all season tourist destination : Pandurang Kondbara Pole Charanjit Singh Channi Reviews Preparedness For Progressive Punjab Investors Summit We Should Fight Anti-National Forces Jointly : Gurpreet Singh Bhullar Commissionerate Police Give Rousing Welcome To Motorcycle Rally On Its Arrival At Jalandhar To Mark National Unity Day

 

WHO validates China's Sinovac Covid vax for emergency use

 Coronavirus, COVID 19, Novel Coronavirus, Fight Against Corona, Covaxin, Covishield, Covid-19 Vaccine, Oxygen, Oxygen Cylinders, SARS-CoV-2, Sputnik V, Oxygen Plants, Pfizer, Astra Zeneca, Oxygen Concentrator, Remdesivir, Covifor, Oxygen supply, Liquid Medical Oxygen, World Health Organisation, WHO, Sinovac-CoronaVac Covid-19 vaccine

Web Admin

Web Admin

5 Dariya News

Geneva , 01 Jun 2021

The World Health Organisation (WHO) on Tuesday validated the Sinovac-CoronaVac Covid-19 vaccine for emergency use, giving countries, procuring agencies and communities the assurance that it meets international standards for safety, efficacy and manufacturing.The vaccine is produced by Beijing-based pharmaceutical company Sinovac."The world desperately needs multiple Covid-19 vaccines to address the huge access inequity across the globe," WHO Assistant Director General for Access to Health Products, Mariangela Simao, said in a statement."We urge manufacturers to participate in the Covax Facility, share their knowhow and data and contribute to bringing the pandemic under control," Simao added.WHO's Emergency Use Listing (EUL) is a prerequisite for Covax facility vaccine supply and international procurement. It also allows countries to expedite their regulatory approval to import and administer Covid-19 vaccines.The EUL assesses the quality, safety and efficacy of Covid-19 vaccines, as well as risk management plans and programmatic suitability, such as cold chain requirements.

The assessment is performed by the product evaluation group, composed of regulatory experts from around the world and a Technical Advisory Group (TAG), in charge of performing the risk-benefit assessment for an independent recommendation on whether a vaccine can be listed for emergency use and, if so, under which conditions.In the case of the Sinovac-CoronaVac vaccine, the WHO assessment included on-site inspections of the production facility.The Sinovac-CoronaVac product is an inactivated vaccine. Its easy storage requirements make it very manageable and particularly suitable for low-resource settings.WHO's Strategic Advisory Group of Experts on Immunisation (SAGE) has also completed its review of the vaccine.Based on available evidence, WHO recommends the vaccine for use in adults 18 years and older, in a two-dose schedule with a spacing of two to four weeks.Vaccine efficacy results showed that the vaccine prevented symptomatic disease in 51 per cent of those vaccinated and prevented severe Covid-19 and hospitalisation in 100 per cent of the studied population.

 

Tags: Coronavirus , COVID 19 , Novel Coronavirus , Fight Against Corona , Covaxin , Covishield , Covid-19 Vaccine , Oxygen , Oxygen Cylinders , SARS-CoV-2 , Sputnik V , Oxygen Plants , Pfizer , Astra Zeneca , Oxygen Concentrator , Remdesivir , Covifor , Oxygen supply , Liquid Medical Oxygen , World Health Organisation , WHO , Sinovac-CoronaVac Covid-19 vaccine

 

 

related news

 

 

 

Photo Gallery

 

 

Video Gallery

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2021 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD